OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
301198 Ningbo Joy Intelligent Logistics Technology
- 10.38
- +0.18+1.76%
Trading Apr 1 13:49 CST
1.75BMarket Cap471.82P/E (TTM)
10.58High10.17Low23.59KlotVolume10.17Open10.20Pre Close24.67MTurnover1.45%Turnover Ratio48.50P/E (Static)169.00MShares17.0052wk High1.87P/B1.68BFloat Cap6.8652wk Low12.24Limit Up162.28MShs Float35.05Historical High8.16Limit Down4.02%Amplitude5.73Historical Low0.12Dividend TTM10.46Avg Price11.71KlotAsk1.16%Div YieldTTM100Lot Size11.23KlotBid
Ningbo Joy Intelligent Logistics Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 3.85%281.53M | 59.77%262.86M | 17.50%307.78M | -20.14%256.11M | 6.06%271.09M | -2.97%164.52M | 153.14%261.94M | -36.74%320.71M | 318.24%255.6M | 528.30%169.55M |
| Transactional financial assets | -67.94%60.04M | -67.35%80.43M | -27.30%141.02M | -3.36%100.01M | -11.15%187.24M | -17.96%246.31M | -47.00%193.99M | --103.49M | --210.73M | --300.24M |
| Notes receivable and accounts receivable | -19.78%197.98M | -17.26%192.42M | -1.27%209.88M | 11.43%263.68M | 19.04%246.81M | 24.29%232.57M | 5.78%212.57M | 26.50%236.63M | 22.90%207.33M | 11.51%187.13M |
| -Notes receivable | --2.91M | --3.15M | --5.34M | --10.27M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Accounts receivable | -20.96%195.07M | -18.62%189.27M | -3.78%204.53M | 7.09%253.41M | 19.04%246.81M | 24.29%232.57M | 6.08%212.57M | 26.50%236.63M | 22.90%207.33M | 11.51%187.13M |
| Other receivables (including interest and dividends) | -34.31%2.93M | -11.70%3.76M | -53.22%1.93M | -29.88%2.93M | 1.39%4.47M | -47.31%4.26M | -32.18%4.13M | 16.76%4.17M | 129.09%4.4M | 377.44%8.08M |
| -Other receivable | ---- | -11.70%3.76M | ---- | ---- | ---- | -47.31%4.26M | ---- | 16.76%4.17M | ---- | 377.44%8.08M |
| Contractual assets | 206.10%854.63K | 594.45%879.44K | 493.06%820.45K | 464.69%781.19K | --279.2K | -44.80%126.64K | --138.34K | -75.07%138.34K | ---- | --229.41K |
| Advance payment | -10.42%14.09M | 50.99%11.83M | 101.66%12.13M | -47.93%4.71M | 46.79%15.73M | 52.79%7.83M | 29.02%6.02M | 138.49%9.05M | 494.81%10.72M | 167.30%5.13M |
| Inventories | 19.89%119.3M | 38.59%123.09M | 20.56%126.29M | 24.53%110.73M | 9.55%99.5M | -9.43%88.82M | 29.71%104.76M | 27.64%88.92M | 46.84%90.83M | 45.88%98.06M |
| Receivable financing | 22.96%10.6M | 795.95%37.82M | -12.82%18.25M | 20.81%5.32M | -40.77%8.62M | -40.64%4.22M | 530.51%20.93M | -27.29%4.4M | 467.85%14.56M | 274.42%7.11M |
| Other current assets | 493.96%13.3M | 643.99%14.05M | 632.39%15.35M | 1,552.89%38.05M | 18.04%2.24M | 270.17%1.89M | -14.09%2.1M | -15.74%2.3M | -63.44%1.9M | -89.94%510.06K |
| Total current assets | -16.19%700.63M | -3.12%727.12M | 3.33%833.45M | 1.62%782.32M | 5.01%835.97M | -3.29%750.54M | 5.06%806.57M | -1.36%769.81M | 162.60%796.07M | 184.69%776.04M |
| Non Current assets | ||||||||||
| Long-term equity investment | -0.44%21.41M | --20.94M | --20.68M | --20.92M | --21.5M | ---- | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | 101.62%292.08M | ---- | ---- | ---- | 7.24%144.87M | ---- | 15.83%149.54M | ---- | 16.98%135.08M |
| Constru in process | ---- | -4.93%76.27M | ---- | ---- | ---- | 442.48%80.23M | ---- | 628.60%61.22M | ---- | -8.20%14.79M |
| Intangible assets | -2.58%53.27M | -2.51%53.66M | -2.12%54.06M | -2.24%54.37M | -1.66%54.68M | 18.87%55.04M | 18.69%55.23M | 18.69%55.62M | 17.78%55.6M | -2.51%46.3M |
| Long deferred expense | 38.15%117.56M | 44.26%117.72M | 59.19%117.49M | 57.55%117.56M | 27.61%85.1M | 40.52%81.6M | 63.27%73.81M | 85.28%74.62M | 82.05%66.69M | 62.09%58.07M |
| Deferred tax assets | -81.44%1.1M | -82.99%1.02M | -67.23%2.84M | 10.76%2.1M | 31.49%5.92M | 39.69%6.02M | 104.94%8.68M | -58.17%1.9M | 9.60%4.5M | 0.45%4.31M |
| Usufruct assets | -23.94%4.42M | -34.93%4.55M | -41.54%4.04M | -43.23%4.52M | -35.51%5.81M | -26.37%7M | -15.68%6.92M | -9.51%7.96M | -13.43%9M | -15.57%9.5M |
| Other non current assets | -62.02%2.19M | -8.35%4.02M | -20.57%3.9M | 118.77%6.08M | 218.01%5.78M | -82.78%4.39M | 169.42%4.91M | 25.91%2.78M | -57.67%1.82M | 461.41%25.47M |
| Total non current assets | 37.86%576.07M | 50.41%570.26M | 49.25%551.84M | 44.80%512.06M | 30.72%417.85M | 29.16%379.13M | 52.08%369.75M | 47.24%353.62M | 35.51%319.66M | 24.91%293.53M |
| Total assets | 1.82%1.28B | 14.85%1.3B | 17.77%1.39B | 15.22%1.29B | 12.38%1.25B | 5.62%1.13B | 16.37%1.18B | 10.08%1.12B | 106.98%1.12B | 110.72%1.07B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 9.39%191.14M | 116.39%220.15M | 100.01%260.25M | 124.98%180.15M | 118.40%174.72M | 45.25%101.74M | 518.94%130.12M | 186.11%80.07M | 86.50%80M | 112.66%70.04M |
| Notes payable and accounts payable | 11.01%77.48M | 29.04%66.48M | 29.65%74.65M | 73.13%116.74M | -0.22%69.79M | -14.91%51.52M | 32.85%57.58M | 37.82%67.43M | 32.40%69.95M | 4.72%60.55M |
| -Notes payable | 186.46%21.63M | -60.80%1.98M | 131.70%5.77M | 216.19%9.26M | 12.21%7.55M | -31.33%5.05M | -23.00%2.49M | -43.22%2.93M | -41.51%6.73M | -57.86%7.35M |
| -Accounts payable | -10.27%55.85M | 38.80%64.5M | 25.03%68.88M | 66.64%107.48M | -1.54%62.24M | -12.64%46.47M | 37.36%55.09M | 47.37%64.5M | 52.97%63.22M | 31.75%53.2M |
| Contract liabilities | -59.92%474.4K | -45.81%755.44K | -63.93%575.14K | -62.26%529.84K | 78.39%1.18M | -6.05%1.39M | -6.94%1.59M | 202.56%1.4M | -45.96%663.55K | 252.54%1.48M |
| Advance receipts | ---- | ---- | ---- | ---- | --310K | ---- | ---- | ---- | ---- | ---- |
| Salaries payable | -15.52%5.66M | -0.99%5.5M | -5.23%4.47M | -15.61%8.78M | 8.55%6.7M | -0.06%5.55M | 7.60%4.71M | 17.78%10.4M | 4.51%6.17M | 8.59%5.56M |
| Taxs payable | -74.53%2.75M | -76.47%1.77M | -46.37%2.68M | -46.80%4.28M | 11.34%10.79M | 22.06%7.52M | -25.34%5M | 66.45%8.04M | 76.58%9.69M | 5.57%6.16M |
| Other payable (including interest and dividends) | -50.54%134.23K | -14.71%184.32K | -39.82%172.32K | 20.03%246.99K | -57.98%271.38K | -68.09%216.11K | -80.66%286.35K | 73.08%205.76K | 181.98%645.82K | 256.34%677.16K |
| -Other payable | ---- | -14.71%184.32K | ---- | ---- | ---- | -68.09%216.11K | ---- | 73.08%205.76K | ---- | 256.34%677.16K |
| Non current liabilities due within one year | 1,555.72%52.98M | 1,315.06%52.92M | 1,789.42%72.45M | 365.58%22.94M | -25.62%3.2M | -5.59%3.74M | 25.31%3.83M | -62.31%4.93M | -69.05%4.3M | 6.88%3.96M |
| Other current liabilities | -51.77%61.67K | -35.62%98.21K | -62.84%74.77K | -61.61%68.88K | -96.91%127.88K | -20.92%152.53K | -26.42%201.19K | 280.89%179.44K | 2,491.61%4.14M | 252.54%192.89K |
| Total current liabilities | 23.80%330.66M | 102.43%347.85M | 104.26%415.32M | 93.29%333.73M | 52.14%267.09M | 15.62%171.83M | 148.05%203.33M | 65.58%172.66M | 43.16%175.55M | 40.10%148.62M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | --20M | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | -40.81%4.71M | -40.75%4.7M | -38.97%5.04M | 164.03%4.86M | 13.84%7.96M | 22.51%7.93M | 34.42%8.26M | -71.21%1.84M | 185.12%6.99M | 148.85%6.47M |
| Lease liabilities | -40.29%1.24M | -44.33%1.48M | -58.64%1.07M | -51.04%1.51M | -50.02%2.08M | -46.46%2.66M | -44.29%2.59M | -40.92%3.08M | -35.88%4.16M | -33.19%4.96M |
| Total non current liabilities | -80.18%5.95M | -41.65%6.18M | -43.67%6.11M | 29.42%6.37M | 169.26%30.04M | -7.40%10.59M | 0.48%10.85M | -57.61%4.92M | 17.70%11.16M | 7.70%11.43M |
| Total liabilities | 13.29%336.62M | 94.07%354.03M | 96.76%421.43M | 91.52%340.1M | 59.14%297.14M | 13.97%182.42M | 130.87%214.19M | 53.24%177.58M | 41.33%186.71M | 37.16%160.06M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%169M | 0.00%169M | 30.00%169M | 30.00%169M | 30.00%169M | 30.00%169M | 30.00%130M | 30.00%130M | 73.33%130M | 73.33%130M |
| Capital reserve funds | -0.03%511.34M | -0.33%511.34M | -7.71%511.34M | -7.37%511.34M | -6.51%511.49M | -6.22%513.05M | -3.99%554.07M | -4.34%552.02M | 361.64%547.08M | 361.64%547.08M |
| Surplus reserve funds | 7.64%33.73M | 7.64%33.73M | 7.64%33.73M | 7.64%33.73M | 20.99%31.34M | 20.99%31.34M | 20.99%31.34M | 20.99%31.34M | 18.70%25.9M | 18.70%25.9M |
| Retained profit | -7.69%225.71M | -1.94%228.98M | 1.25%249.46M | 3.33%239.87M | 8.17%244.52M | 13.06%233.51M | 14.55%246.38M | 15.09%232.14M | 17.97%226.05M | 17.64%206.53M |
| Shareholders equity without minority interests | -1.73%939.78M | -0.41%943.05M | 0.18%963.53M | 0.89%953.94M | 2.94%956.35M | 4.11%946.9M | 4.76%961.78M | 4.51%945.5M | 128.29%929.03M | 132.68%909.51M |
| Minority interests | -11.89%295.62K | -10.97%312.62K | -4.41%331.19K | -4.87%340.25K | 35,909.78%335.52K | 5,153.54%351.14K | --346.48K | --357.66K | --931.75 | --6.68K |
| Total shareholder equity | -1.74%940.08M | -0.41%943.36M | 0.18%963.86M | 0.89%954.28M | 2.98%956.69M | 4.15%947.25M | 4.80%962.13M | 4.55%945.86M | 128.29%929.03M | 132.68%909.51M |
| Total liabilityies and equity | 1.82%1.28B | 14.85%1.3B | 17.77%1.39B | 15.22%1.29B | 12.38%1.25B | 5.62%1.13B | 16.37%1.18B | 10.08%1.12B | 106.98%1.12B | 110.72%1.07B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.